Ketogenic Diet Shifts Obese Teens' Metabolism Toward Healthy Controls Within Three Months
In 60 adolescents with obesity, a carbohydrate-restricted diet shifted the blood metabolome toward healthy controls faster than a standard diet, though gaps narrowed by 12 months.
Summary
Obesity that starts in childhood often continues into adulthood and raises later health risk. Spanish researchers compared two diets with similar calorie restriction in 60 adolescents with obesity: one restricted carbohydrates and one did not. They also studied 40 healthy peers. Blood was profiled at baseline, 3 months and 12 months using metabolomics, which measures hundreds of small molecules at once. At 3 months, the low-carbohydrate group had larger drops in BMI-SDS, insulin, insulin resistance (HOMA), triglycerides and leptin. Their metabolic profile shifted mostly in lipids and amino acids, in a healthier direction than the standard diet group. By 12 months the differences between the two diet groups had faded, but the low-carbohydrate group's profile still sat closer to that of healthy controls. This is a modest, abstract-only human study using surrogate markers, so it does not show that the diet lowers later disease or extends healthspan.
Detailed Summary
Excess body fat in childhood tends to persist into adulthood, carrying forward risks for insulin resistance, cardiovascular disease and earlier functional decline. Finding diets that correct metabolic disturbance early, not just weight, is therefore of interest to anyone thinking about healthspan.
This study from Madrid and Toulouse followed 60 adolescents with obesity (36 females, 24 males) for 12 months. They were assigned to either a carbohydrate-restricted (CH-R) diet or a non-restricted (CH-N) diet, both with similar calorie restriction. Forty healthy controls (24 females, 16 males) provided a reference. Researchers measured body size, clinical labs and the blood metabolome at baseline, 3 months and 12 months, using two mass spectrometry platforms (CE-TOF-MS and U(H)PLC-QTOF-MS/MS).
At 3 months, the CH-R group had significantly greater reductions in BMI-SDS, insulin, HOMA, triglycerides and leptin. Their metabolome changed mainly in lipids, which made up 76% of the altered metabolites, and amino acids, at 16%. The authors interpret this pattern as a clear metabolic improvement over the CH-N group. By 12 months the between-group metabolomic differences were attenuated, yet the CH-R group's signature remained closer to healthy controls than the CH-N group's. The authors report that the shift persisted after normalizing for carbohydrate intake.
The mechanism signal is that carbohydrate restriction rapidly reshapes lipid and amino acid metabolism toward a healthy profile, alongside better insulin and triglyceride markers. This concerns mechanism and surrogate markers; the abstract does not report long-term function, disease outcomes or lifespan.
Caveats: the abstract does not say whether assignment was randomized, and the convergence by 12 months suggests the early advantage may fade, possibly because of adherence. The abstract reports no harms or adverse effects, so safety cannot be judged. Metabolomic signatures are surrogates, and this summary rests on the abstract alone.
Key Findings
- At 3 months, carbohydrate restriction produced larger drops in BMI-SDS, insulin, HOMA, triglycerides and leptin than a non-restricted diet with similar calories.
- Metabolomic changes were mostly lipids (76%) and amino acids (16%), pointing to a rapid shift in lipid and amino acid metabolism.
- By 12 months, metabolomic differences between the two diet groups were attenuated, so the early advantage narrowed.
- The carbohydrate-restricted group's 12-month metabolomic signature remained closer to healthy controls than the non-restricted group's.
- No function, disease-outcome or lifespan data were reported in the abstract; findings concern mechanism and surrogate markers.
Methodology
Longitudinal study of 60 adolescents with obesity (36 females, 24 males) assigned to carbohydrate-restricted or non-restricted diets with similar calorie restriction for 12 months, plus 40 healthy controls. Clinical, anthropometric and metabolomic data (CE-TOF-MS and U(H)PLC-QTOF-MS/MS) were collected at baseline, 3 and 12 months. The authors declare no competing interests.
Study Limitations
This summary is based on the abstract only, so randomization, adherence, dropout, pubertal stage and statistical details are unavailable. Differences narrowed by 12 months, and the abstract reports no harms, safety data or hard outcomes. The sample is modest and metabolomic signatures are surrogate markers.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
